Ethics Review of Pediatric Multi-Center Drug Trials

Pediatric Drugs

Volumn 17, Issue 1, 2015, Pages 23-30

  Needham, Allison C ^a   Kapadia, Mufiza Z ^a   Offringa, Martin ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ARTICLE; COMPENSATION; DRUG EFFICACY; DRUG SAFETY; EVALUATION STUDY; HUMAN; MULTICENTER STUDY (TOPIC); PEDIATRICS; PRIORITY JOURNAL; PROFESSIONAL STANDARD; REIMBURSEMENT; RESEARCH ETHICS; CHILD; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; ETHICS; METHODOLOGY;

CHILD; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMANS; MULTICENTER STUDIES AS TOPIC; PEDIATRICS; RESEARCH DESIGN;

EID: 84921885450     PISSN: 11745878     EISSN: 11792019     Source Type: Journal    
DOI: 10.1007/s40272-014-0098-9     Document Type: Article

References (59)

1. Caldwell PH, Butow PN, Craig JC. Pediatricians’ attitudes toward randomized controlled trials involving children. J Pediatr. 2002;141(6):798–803. doi:10.1067/mpd.2002.129173.
2. Caldwell PH, Butow PN, Craig JC. Parents’ attitudes to children’s participation in randomized controlled trials. J Pediatr. 2003;142(5):554–9. doi:10.1067/mpd.2003.192.
3. Conroy S, Choonara I, Impicciatore P, Mohn A, Arnell H, Rane A, et al. Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children. BMJ. 2000;320(7227):79–82.
4. Pandolfini C, Bonati M. A literature review on off-label drug use in children. Eur J Pediatr. 2005;164(9):552–8. doi:10.1007/s00431-005-1698-8.
5. Gunnell D, Ashby D. Antidepressants and suicide: what is the balance of benefit and harm. BMJ. 2004;329(7456):34–8. doi:10.1136/bmj.329.7456.34.
6. Mulhall A, de Louvois J, Hurley R. Chloramphenicol toxicity in neonates: its incidence and prevention. Br Med J. 1983;287(6403):1424–7.
7. Bellis JR, Kirkham JJ, Thiesen S, Conroy EJ, Bracken LE, Mannix HL, et al. Adverse drug reactions and off-label and unlicensed medicines in children: a nested case–control study of inpatients in a pediatric hospital. BMC Med. 2013;11:238. doi:10.1186/1741-7015-11-238.
8. Klassen TP, Hartling L, Craig JC, Offringa M. Children are not just small adults: the urgent need for high-quality trial evidence in children. PLoS Med. 2008;5(8):e172. doi:10.1371/journal.pmed.0050172.
9. de Wildt SN. Profound changes in drug metabolism enzymes and possible effects on drug therapy in neonates and children. Expert Opin Drug Metab Toxicol. 2011;7(8):935–48. doi:10.1517/17425255.2011.577739.
10. Mooij MG, Schwarz UI, de Koning BA, Leeder JS, Gaedigk R, Samsom JN, et al. Ontogeny of human hepatic and intestinal transporter gene expression during childhood: age matters. Drug Metab Dispos Biol Fate Chem. 2014;42(8):1268–74. doi:10.1124/dmd.114.056929.
11. Kipnis K. Seven vulnerabilities in the pediatric research subject. Theor Med Bioethics. 2003;24(2):107–20.
12. Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical? JAMA J Am Med Assoc. 2000;283(20):2701–11.
13. Altavilla A. Ethical key issues and fundamental rights in paediatric research. Eur J Clin Pharmacol. 2011;67(Suppl 1):117–23. doi:10.1007/s00228-010-0929-8.
14. Canadian Institutes of Health Research and Social Sciences and Humanities Research Council of Canada. Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans. 2010.
15. Miller PB, Kenny NP. Walking the moral tightrope: respecting and protecting children in health-related research. Camb Q Healthc Ethics CQ Int J Healthc Ethics Comm. 2002;11(3):217–29.
16. Shah S, Whittle A, Wilfond B, Gensler G, Wendler D. How do institutional review boards apply the federal risk and benefit standards for pediatric research? JAMA J Am Med Assoc. 2004;291(4):476–82. doi:10.1001/jama.291.4.476.
17. European Organisation for Rare Diseases. 2009.What is a rare disease? http://www.eurordis.org/content/what-rare-disease. Accessed 24 Sept 2013.
18. Goldberg JD, Koury KJ. Design and analysis of multicenter trials. In: Berry DA, editor. Statistical methodology in the pharmaceutical industry. New York: Dekker; 1990. p. 201–37.
19. Tenembaum SN. Ethical challenges in paediatric clinical trials in multiple sclerosis. Ther Adv Neurol Disord. 2012;5(3):139–46. doi:10.1177/1756285612437360.
20. Slora EJ, Harris DL, Bocian AB, Wasserman RC. Pediatric clinical research networks: current status, common challenges, and potential solutions. Pediatrics. 2010;126(4):740–5. doi:10.1542/peds.2009-3586.
21. Hagen NA, Stiles CR, Biondo PD, Cummings GG, Fainsinger RL, Moulin DE, et al. Establishing a multicentre clinical research network: lessons learned. Curr Oncol. 2011;18(5):e243–9.
22. Union E. Ethical considerations for clinical trials on medicinal products conducted with the paediatric population. Eur J Health Law. 2008;15(2):223–50.
23. Gill D, Ethics Working Group of the Confederation of European Specialists in P. Ethical principles and operational guidelines for good clinical practice in paediatric research. Recommendations of the Ethics Working Group of the Confederation of European Specialists in Paediatrics (CESP). Eur J Pediatr. 2004;163(2):53–7. doi:10.1007/s00431-003-1378-5.
24. Avard D, Samuël J, Black L, Griener G, Knoppers BM. Best practices for health research involving children and adolescents. 2011. Centre of Genomics and Policy, McGill University Ethics Office, Canadian Institutes of Health Research. http://www.pediagen.org/ressources/BestPratices.pdf. Accessed 28 May 2014.
25. Cheah P, Parker M. Consent and assent in paediatric research in low-income settings. BMC Med Ethics. 2014;15(1):22.
26. Roth-Cline M, Gerson J, Bright P, Lee CS, Nelson RM. Ethical considerations in conducting pediatric research. Pediatr Clin Pharmacol. 2011;205:219–44. doi:10.1007/978-3-642-20195-0_11.
27. Fernandez C. Ethical issues in health research in children. Paediatr Child Health. 2008;13(8):707–20.
28. Bratton SL, Odetola FO, McCollegan J, Cabana MD, Levy FH, Keenan HT. Regional variation in ICU care for pediatric patients with asthma. J Pediatr. 2005;147(3):355–61. doi:10.1016/j.jpeds.2005.05.008.
29. Hyder AA, Dawson L. Defining standard of care in the developing world: the intersection of international research ethics and health systems analysis. Dev World Bioethics. 2005;5(2):142–52. doi:10.1111/j.1471-8847.2005.00109.x.
30. Dickert N, Emanuel E, Grady C. Paying research subjects: an analysis of current policies. Ann Intern Med. 2002;136(5):368–73.
31. Caldwell PH, Dans L, de Vries MC, Newman Ba Hons J, Sammons H, Spriggs MBM, et al. Standard 1: consent and recruitment. Pediatrics. 2012;129(Suppl 3):S118–23. doi:10.1542/peds.2012-0055D.
32. Altavilla A, Manfredi C, Baiardi P, Dehlinger-Kremer M, Galletti P, Pozuelo AA, et al. Impact of the new European paediatric regulatory framework on ethics committees: overview and perspectives. Acta Paediatr. 2012;101(1):e27–32. doi:10.1111/j.1651-2227.2011.02401.x.
33. Matheson LA, Huber AM, Warner A, Rosenberg AM. Ethics application protocols for multicentre clinical studies in Canada: a paediatric rheumatology experience. Paediatr Child Health. 2012;17(6):313–6.
34. Ahmed AH, Nicholson KG. Delays and diversity in the practice of local research ethics committees. J Med Ethics. 1996;22(5):263–6.
35. Greene SM, Geiger AM. A review finds that multicenter studies face substantial challenges but strategies exist to achieve Institutional Review Board approval. J Clin Epidemiol. 2006;59(8):784–90. doi:10.1016/j.jclinepi.2005.11.018.
36. McWilliams R, Hoover-Fong J, Hamosh A, Beck S, Beaty T, Cutting G. Problematic variation in local institutional review of a multicenter genetic epidemiology study. JAMA J Am Med Assoc. 2003;290(3):360–6. doi:10.1001/jama.290.3.360.
37. Dal-Re R, Morejon E, Ortega R. Nature and extent of changes in the patient’s information sheets of international multicentre clinical trials as requested by Spanish Research Ethics Committees. Med Clin. 2004;123(20):770–4.
38. Stair TO, Reed CR, Radeos MS, Koski G, Camargo CA. Variation in institutional review board responses to a standard protocol for a multicenter clinical trial. Acad Emerg Med. 2001;8(6):636–41.
39. Rogers AS, Schwartz DF, Weissman G, English A. Adolescent medicine HIVARN. A case study in adolescent participation in clinical research: eleven clinical sites, one common protocol, and eleven IRBs. IRB. 1999;21(1):6–10.
40. Silverman H, Hull SC, Sugarman J. Variability among institutional review boards’ decisions within the context of a multicenter trial. Crit Care Med. 2001;29(2):235–41.
41. Jamrozik K. The case for a new system for oversight of research on human subjects. J Med Ethics. 2000;26(5):334–9.
42. Higgerson RA, Olsho LE, Christie LM, Rehder K, Doksum T, Gedeit R, et al. Variability in IRBs regarding parental acceptance of passive consent. Pediatrics. 2014;134(2):e496–503. doi:10.1542/peds.2013-4190.
43. Mansbach J, Acholonu U, Clark S, Camargo CA Jr. Variation in institutional review board responses to a standard, observational, pediatric research protocol. Acad Emerg Med Off J Soc Acad Emerg Med. 2007;14(4):377–80. doi:10.1197/j.aem.2006.11.031.
44. Ezzat H, Ross S, von Dadelszen P, Morris T, Liston R, Magee LA, et al. Ethics review as a component of institutional approval for a multicentre continuous quality improvement project: the investigator’s perspective. BMC Health Serv Res. 2010;10:223. doi:10.1186/1472-6963-10-223.
45. Emanuel EJ, Wood A, Fleischman A, Bowen A, Getz KA, Grady C, et al. Oversight of human participants research: identifying problems to evaluate reform proposals. Ann Intern Med. 2004;141(4):282–91.
46. Saginur R, Dent SF, Schwartz L, Heslegrave R, Stacey S, Manzo J. Ontario Cancer Research Ethics Board: lessons learned from developing a multicenter regional institutional review board. J Clin Oncol Off J Am Soc Clin Oncol. 2008;26(9):1479–82. doi:10.1200/JCO.2007.12.6441.
47. Wagner TH, Murray C, Goldberg J, Adler JM, Abrams J. Costs and benefits of the national cancer institute central institutional review board. J Clin Oncol Off J Am Soc Clin Oncol. 2010;28(4):662–6. doi:10.1200/JCO.2009.23.2470.
48. Health Research Ethics Authority. 2014. Welcome to the Health Research Ethics Authority (HREA) Website. http://www.hrea.ca/Home.aspx. Accessed 26 June 2014.
49. Province of Alberta. 2000. Health Information Act. https://www.assembly.ab.ca/HIAReview/Health_Information_Act.pdf. Accessed 26 June 2014.
50. Health Research Ethics Board of Alberta. 2014. Coming soon: one ethics review for health research in Alberta. http://hreba.ca/coming-soon-one-ethics-review-for-health-research-in-alberta/. Accessed 26 June 2014.
51. Clinical Trials Ontario. 2014. Streamlined research ethics review. http://www.ctontario.ca/streamlined-ethics-review-system/. Accessed 28 June 2014.
52. European Forum for Good Clinical Practice. 2012. EFGCP report on the procedure for the ethical review of protocols for clinical research Projects in Europe and beyond. http://www.efgcp.eu/EFGCPReports.asp?L1=5&L2=1. Accessed 16 Sept 2014.
53. Australian Government National Health and Medical Research Council. 2014. The National approach to single ethical review of multi-centre research. http://hrep.nhmrc.gov.au/national-approach. Data accessed 24 Sept 2014.
54. Maternal Infant Child and Youth Network. 2011. MICRYN workshop: research ethics harmonization. http://www.micyrn.ca/PDF/REBWorkshopReportOctober2011.pdf. Accessed 29 July 2013.
55. Pinkerton CR, Ablett S, Boos J, Philip T. Ethical approval for multicentre clinical trials in children. Contrasting systems in three European countries. Eur J Cancer. 2002;38(8):1051–8.
56. Enzel ME, Schmaltz R. Ethics review of multi-centre clinical trials in Canada. Health Law Rev. 2005;13(2–3):51–7.
57. Coleman CH, Bouesseau MC. How do we know that research ethics committees are really working? The neglected role of outcomes assessment in research ethics review. BMC Med Ethics. 2008;9:6. doi:10.1186/1472-6939-9-6.
58. Abbott L, Grady C. A systematic review of the empirical literature evaluating IRBs: what we know and what we still need to learn. J Empir Res Hum Res Ethics JERHRE. 2011;6(1):3–19. doi:10.1525/jer.2011.6.1.3.
59. de Jong JP, van Zwieten MC, Willems DL. Ethical review from the inside: repertoires of evaluation in Research Ethics Committee meetings. Sociol Health Illn. 2012;34(7):1039–52. doi:10.1111/j.1467-9566.2012.01458.x.